The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 06 2021 for Axis Clinic Ltd Trident Chemphar Ltd & RPR Sons Advisors Pvt Ltd. (Jointly holding)
Aurobindo Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
April 6, 2021
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month